Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24531

1.

Cannabis effects on lipoproteins.

Lazarte J, Hegele RA.

Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000575. [Epub ahead of print]

PMID:
30649023
2.

Ethanol and cannabinoids interact to alter behavior in a zebrafish fetal alcohol spectrum disorder model.

Boa-Amponsem O, Zhang C, Mukhopadhyay S, Ardrey I, Cole GJ.

Birth Defects Res. 2019 Jan 16. doi: 10.1002/bdr2.1458. [Epub ahead of print]

PMID:
30648819
3.

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold.

Cooper AG, Oyagawa CRM, Manning JJ, Singh S, Hook S, Grimsey NL, Glass M, Tyndall JDA, Vernall AJ.

Medchemcomm. 2018 Oct 23;9(12):2055-2067. doi: 10.1039/c8md00448j. eCollection 2018 Dec 1.

PMID:
30647881
4.

Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases.

Fitzcharles MA, Zahedi Niaki O, Hauser W, Hazlewood G; the Canadian Rheumatology Association.

J Rheumatol. 2019 Jan 15. pii: jrheum.181120. doi: 10.3899/jrheum.181120. [Epub ahead of print]

PMID:
30647183
5.

The role of the endocannabinoid system in female reproductive tissues.

Walker OLS, Holloway AC, Raha S.

J Ovarian Res. 2019 Jan 15;12(1):3. doi: 10.1186/s13048-018-0478-9. Review.

PMID:
30646937
6.

Analysis of Terpenes in Cannabis sativa L. Using GC/MS: Method Development, Validation, and Application.

Ibrahim EA, Wang M, Radwan MM, Wanas AS, Majumdar CG, Avula B, Wang YH, Khan IA, Chandra S, Lata H, Hadad GM, Abdel Salam RA, Ibrahim AK, Ahmed SA, ElSohly MA.

Planta Med. 2019 Jan 15. doi: 10.1055/a-0828-8387. [Epub ahead of print]

PMID:
30646402
7.

Peering Through the Haze of Smoked vs Vaporized Cannabis-To Vape or Not to Vape?

Solowij N.

JAMA Netw Open. 2018 Nov 2;1(7):e184838. doi: 10.1001/jamanetworkopen.2018.4838. No abstract available.

PMID:
30646385
8.

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis.

Torres-Moreno MC, Papaseit E, Torrens M, Farré M.

JAMA Netw Open. 2018 Oct 5;1(6):e183485. doi: 10.1001/jamanetworkopen.2018.3485.

PMID:
30646241
9.

Cannabinoids for Symptoms of Multiple Sclerosis: Benefits to Patients Still Unclear.

Slaven M, Levine O.

JAMA Netw Open. 2018 Oct 5;1(6):e183484. doi: 10.1001/jamanetworkopen.2018.3484. No abstract available.

PMID:
30646233
10.

Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior.

Shen CJ, Zheng D, Li KX, Yang JM, Pan HQ, Yu XD, Fu JY, Zhu Y, Sun QX, Tang MY, Zhang Y, Sun P, Xie Y, Duan S, Hu H, Li XM.

Nat Med. 2019 Jan 14. doi: 10.1038/s41591-018-0299-9. [Epub ahead of print]

PMID:
30643290
11.

Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Orr C, Spechler P, Cao Z, Albaugh M, Chaarani B, Mackey S, D'Souza D, Allgaier N, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Burke Quinlan E, Conrod P, Desrivières S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillère Martinot ML, Nees F, Papadopoulos Orfanos D, Paus T, Poustka L, Millenet S, Fröhner JH, Radhakrishnan R, Smolka MN, Walter H, Whelan R, Schumann G, Potter A, Garavan H.

J Neurosci. 2019 Jan 14. pii: 3375-17. doi: 10.1523/JNEUROSCI.3375-17.2018. [Epub ahead of print]

PMID:
30643026
12.

MicroRNA-29a Attenuates Diabetic Glomerular Injury through Modulating Cannabinoid Receptor 1 Signaling.

Tung CW, Ho C, Hsu YC, Huang SC, Shih YH, Lin CL.

Molecules. 2019 Jan 11;24(2). pii: E264. doi: 10.3390/molecules24020264.

PMID:
30642005
13.

Arachidonoyl Serotonin (AA-5-HT) Modulates General Fear-Like Behavior and Inhibits Mesolimbic Dopamine Release.

Freels TG, Lester DB, Cook MN.

Behav Brain Res. 2019 Jan 10. pii: S0166-4328(18)31287-7. doi: 10.1016/j.bbr.2019.01.010. [Epub ahead of print]

PMID:
30639609
14.

Crystal Structure of the Human Cannabinoid Receptor CB2.

Li X, Hua T, Vemuri K, Ho JH, Wu Y, Wu L, Popov P, Benchama O, Zvonok N, Locke K, Qu L, Han GW, Iyer MR, Cinar R, Coffey NJ, Wang J, Wu M, Katritch V, Zhao S, Kunos G, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ.

Cell. 2018 Dec 21. pii: S0092-8674(18)31625-8. doi: 10.1016/j.cell.2018.12.011. [Epub ahead of print]

PMID:
30639103
15.

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.

Krishna Kumar K, Shalev-Benami M, Robertson MJ, Hu H, Banister SD, Hollingsworth SA, Latorraca NR, Kato HE, Hilger D, Maeda S, Weis WI, Farrens DL, Dror RO, Malhotra SV, Kobilka BK, Skiniotis G.

Cell. 2018 Dec 21. pii: S0092-8674(18)31565-4. doi: 10.1016/j.cell.2018.11.040. [Epub ahead of print]

PMID:
30639101
16.

A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.

Hädener M, Vieten S, Weinmann W, Mahler H.

Forensic Sci Int. 2019 Jan 6. pii: S0379-0738(18)30847-8. doi: 10.1016/j.forsciint.2018.12.021. [Epub ahead of print]

PMID:
30638755
17.

Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis.

Briscoe J, Kamal AH, Casarett DJ.

J Palliat Med. 2019 Jan 14. doi: 10.1089/jpm.2018.0641. [Epub ahead of print]

PMID:
30638427
18.

9-Tetrahydrocannabinol, a major marijuana component, enhances the anesthetic effect of pentobarbital through the CB1 receptor.

Kimura T, Takaya M, Usami N, Watanabe K, Yamamoto I.

Forensic Toxicol. 2019;37(1):207-214. doi: 10.1007/s11419-018-0457-2. Epub 2018 Nov 24.

20.

Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and/or serum specimens obtained from three individuals by LC-QTRAP-MS/MS and high-resolution LC-Orbitrap-MS/MS.

Minakata K, Hasegawa K, Nozawa H, Yamagishi I, Saitoh T, Yoshino A, Suzuki M, Kitamoto T, Suzuki O, Watanabe K.

Forensic Toxicol. 2019;37(1):164-173. doi: 10.1007/s11419-018-0448-3. Epub 2018 Oct 16.

Supplemental Content

Loading ...
Support Center